AIL
BIO icon

AGF Investments LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

AGF Investments LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-145
Closed -$82K – 391
2022
Q1 		$82K Buy
+145
New +$87.4K 0.01% 328
2021
Q2 		– Sell
-1,184
Closed -$676K – 436
2021
Q1 		$676K Sell
1,184
-306
-21% -$181K 0.08% 115
2020
Q4 		$869K Sell
1,490
-2,167
-59% -$1.23M 0.1% 84
2020
Q3 		$1.89M Sell
3,657
-2,176
-37% -$1.1M 0.21% 29
2020
Q2 		$2.63M Buy
5,833
+3,626
+164% +$1.6M 0.27% 42
2020
Q1 		$774K Buy
+2,207
New +$811K 0.1% 143
2019
Q3 		– Sell
-30
Closed -$9K – 643
2019
Q2 		$9K Hold
30
– – ﹤0.01% 514
2019
Q1 		$9K Hold
30
– – ﹤0.01% 499
2018
Q4 		$7K Hold
30
– – ﹤0.01% 601
2018
Q3 		$9K Sell
30
-30
-50% -$9.31K ﹤0.01% 659
2018
Q2 		$18 Buy
60
+30
+100% +$8.28K ﹤0.01% 643
2018
Q1 		$8K Buy
+30
New +$7.64K ﹤0.01% 529
2017
Q4 		– Sell
-234
Closed -$53K – 753
2017
Q3 		$53K Sell
234
-10
-4% -$2.25K 0.01% 227
2017
Q2 		$55K Buy
244
+16
+7% +$3.49K 0.01% 232
2017
Q1 		$46K Buy
228
+170
+293% +$32.7K 0.01% 188
2016
Q4 		$11K Buy
+58
New +$9.89K ﹤0.01% 500

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AGF Investments LLC's BIO Position: Q2 2022 in Review

AGF Investments LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2022, closing a stake of 145 shares — an estimated $82K sold.

AGF Investments LLC first reported a position in BIO in Q4 2016 and held it in 16 quarters. The position peaked at $2.63M in Q2 2020. 501 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • AGF Investments LLC reported no remaining Bio-Rad Laboratories Class A position as of Q2 2022 after selling out during the quarter.
  • AGF Investments LLC sold 145 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $82K.
  • AGF Investments LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 16 quarters.
  • AGF Investments LLC's Bio-Rad Laboratories Class A position peaked at $2.63M in Q2 2020.
  • 501 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on AGF Investments LLC's 13F filing for Q2 2022, filed 12 Aug 2022.